Literature DB >> 10076484

Radon and lung cancer: a cost-effectiveness analysis.

E S Ford1, A E Kelly, S M Teutsch, S B Thacker, P L Garbe.   

Abstract

OBJECTIVES: This study examined the cost-effectiveness of general and targeted strategies for residential radon testing and mitigation in the United States.
METHODS: A decision-tree model was used to perform a cost-effectiveness analysis of preventing radon-associated deaths from lung cancer.
RESULTS: For a radon threshold of 4 pCi/L, the estimated costs to prevent 1 lung cancer death are about $3 million (154 lung cancer deaths prevented), or $480,000 per life-year saved, based on universal radon screening and mitigation, and about $2 million (104 lung cancer deaths prevented), or $330,000 per life-year saved, if testing and mitigation are confined to geographic areas at high risk for radon exposure. For mitigation undertaken after a single screening test and after a second confirmatory test, the estimated costs are about $920,000 and $520,000, respectively, to prevent a lung cancer death with universal screening and $130,000 and $80,000 per life-year for high risk screening. The numbers of preventable lung cancer deaths are 811 and 527 for universal and targeted approaches, respectively.
CONCLUSIONS: These data suggest possible alternatives to current recommendations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10076484      PMCID: PMC1508623          DOI: 10.2105/ajph.89.3.351

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  18 in total

1.  Uncertainties about health effects of radon.

Authors:  P H Abelson
Journal:  Science       Date:  1990-10-19       Impact factor: 47.728

2.  Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking.

Authors:  G Oster; D M Huse; T E Delea; G A Colditz
Journal:  JAMA       Date:  1986-09-12       Impact factor: 56.272

3.  Radon retesting and mitigation behavior among the U.S. population.

Authors:  E S Ford; C R Eheman
Journal:  Health Phys       Date:  1997-04       Impact factor: 1.316

4.  The economic costs of the health effects of smoking, 1984.

Authors:  D P Rice; T A Hodgson; P Sinsheimer; W Browner; A N Kopstein
Journal:  Milbank Q       Date:  1986       Impact factor: 4.911

5.  Radon awareness and testing behavior: findings from the Behavioral Risk Factor Surveillance System, 1989-1992.

Authors:  E S Ford; C R Eheman; P Z Siegel; P L Garbe
Journal:  Health Phys       Date:  1996-03       Impact factor: 1.316

6.  Cost evaluation of control measures for indoor radon progeny.

Authors:  D W Moeller; K Fujimoto
Journal:  Health Phys       Date:  1984-06       Impact factor: 1.316

Review 7.  Review of radon and lung cancer risk.

Authors:  J M Samet; R W Hornung
Journal:  Risk Anal       Date:  1990-03       Impact factor: 4.000

8.  The cost-effectiveness of counseling smokers to quit.

Authors:  S R Cummings; S M Rubin; G Oster
Journal:  JAMA       Date:  1989-01-06       Impact factor: 56.272

9.  EPA's perspective on risks from residential radon exposure.

Authors:  J S Puskin; C B Nelson
Journal:  JAPCA       Date:  1989-07

10.  Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling.

Authors:  K Fiscella; P Franks
Journal:  JAMA       Date:  1996-04-24       Impact factor: 56.272

View more
  4 in total

1.  Lung cancer efforts need stronger emphasis on reducing radon exposure.

Authors:  Susan M Conrath; David J Pawel
Journal:  Am J Public Health       Date:  2013-07-18       Impact factor: 9.308

2.  Radon, smoking, and lung cancer: the need to refocus radon control policy.

Authors:  Paula M Lantz; David Mendez; Martin A Philbert
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

3.  Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them.

Authors:  Alastair Gray; Simon Read; Paul McGale; Sarah Darby
Journal:  BMJ       Date:  2009-01-06

4.  Radon control activities for lung cancer prevention in national comprehensive cancer control program plans, 2005-2011.

Authors:  Antonio Neri; Sherri L Stewart; William Angell
Journal:  Prev Chronic Dis       Date:  2013-08-08       Impact factor: 2.830

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.